Description
Integrated discussion of how nutritional therapies combining MCFAs and omega-3 PUFAs may address multiple pathological mechanisms in Alzheimer's disease and other neurodegenerative disorders.
Figure 9
Source Paper
The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer's …Cite This Figure
![Figure 9: Integrated discussion of how nutritional therapies combining MCFAs and omega-3 PUFAs may address multiple pathological mechanisms in Alzheimer's disease and other neurodegenerative disorders.]() > Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." *Antioxidants (Basel, Switzerland)*, 2021. PMID: [34943094](https://pubmed.ncbi.nlm.nih.gov/34943094/)
<figure> <img src="" alt="Integrated discussion of how nutritional therapies combining MCFAs and omega-3 PUFAs may address multiple pathological mechanisms in Alzheimer's disease and other neurodegenerative disorders." /> <figcaption>Figure 9. Integrated discussion of how nutritional therapies combining MCFAs and omega-3 PUFAs may address multiple pathological mechanisms in Alzheimer's disease and other neurodegenerative disorders.<br> Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." <em>Antioxidants (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34943094/">34943094</a></figcaption> </figure>